Cargando…

Differential effects of deep brain stimulation and levodopa on brain activity in Parkinson’s disease

Levodopa is the first-line treatment for Parkinson’s disease, although the precise mechanisms mediating its efficacy remain elusive. We aimed to elucidate treatment effects of levodopa on brain activity during the execution of fine movements and to compare them with deep brain stimulation of the sub...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mueller, Karsten, Urgošík, Dušan, Ballarini, Tommaso, Holiga, Štefan, Möller, Harald E, Růžička, Filip, Roth, Jan, Vymazal, Josef, Schroeter, Matthias L, Růžička, Evžen, Jech, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425344/ https://www.ncbi.nlm.nih.gov/pubmed/32954278 http://dx.doi.org/10.1093/braincomms/fcaa005

Ejemplares similares

Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease
por: Mueller, Karsten, et al.
Publicado: (2018)

Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
por: Mueller, Karsten, et al.
Publicado: (2018)

Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstem
por: Holiga, Štefan, et al.
Publicado: (2015)

Weight Gain Is Associated with Medial Contact Site of Subthalamic Stimulation in Parkinson's Disease
por: Růžička, Filip, et al.
Publicado: (2012)

The Subthalamic Microlesion Story in Parkinson's Disease: Electrode Insertion-Related Motor Improvement with Relative Cortico-Subcortical Hypoactivation in fMRI
por: Jech, Robert, et al.
Publicado: (2012)

Motor Matters: Tackling Heterogeneity of Parkinson’s Disease in Functional MRI Studies
por: Holiga, Štefan, et al.
Publicado: (2013)

Regional gray matter changes and age predict individual treatment response in Parkinson's disease
por: Ballarini, Tommaso, et al.
Publicado: (2018)

Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
por: Ballarini, Tommaso, et al.
Publicado: (2018)

General and selective brain connectivity alterations in essential tremor: A resting state fMRI study
por: Mueller, Karsten, et al.
Publicado: (2017)

The Instrumental Activities of Daily Living in Parkinson’s Disease Patients Treated by Subthalamic Deep Brain Stimulation
por: Bezdicek, Ondrej, et al.
Publicado: (2022)

Separate neural representations of depression, anxiety and apathy in Parkinson’s disease
por: Dan, Rotem, et al.
Publicado: (2017)

Accounting for Movement Increases Sensitivity in Detecting Brain Activity in Parkinson's Disease
por: Holiga, Štefan, et al.
Publicado: (2012)

Abnormal Activity in the Precuneus during Time Perception in Parkinson's Disease: An fMRI Study
por: Dušek, Petr, et al.
Publicado: (2012)

Basal Ganglia Neuronal Activity during Scanning Eye Movements in Parkinson’s Disease
por: Sieger, Tomáš, et al.
Publicado: (2013)

Topography of emotional valence and arousal within the motor part of the subthalamic nucleus in Parkinson’s disease
por: Serranová, Tereza, et al.
Publicado: (2019)

Benefits of pallidal stimulation in dystonia are linked to cerebellar volume and cortical inhibition
por: Fečíková, Anna, et al.
Publicado: (2018)

Frequency-phase analysis of resting-state functional MRI
por: Goelman, Gadi, et al.
Publicado: (2017)

Corrigendum: Frequency-phase analysis of resting-state functional MRI
por: Goelman, Gadi, et al.
Publicado: (2017)

Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI Study
por: Mueller, Karsten, et al.
Publicado: (2017)

Symptom-severity-related brain connectivity alterations in functional movement disorders
por: Mueller, Karsten, et al.
Publicado: (2022)

Does serial administration of gadolinium‐based contrast agents affect patient neurological and neuropsychological status? Fourteen‐year follow‐up of patients receiving more than fifty contrast administrations
por: Vymazal, Josef, et al.
Publicado: (2019)

3D visual cueing shortens the double support phase of the gait cycle in patients with advanced Parkinson's disease treated with DBS of the STN
por: Poláková, Kamila, et al.
Publicado: (2020)

Predicting Falls in Parkinson Disease: What Is the Value of Instrumented Testing in OFF Medication State?
por: Hoskovcová, Martina, et al.
Publicado: (2015)

Physiotherapy in Parkinson's Disease: Building ParkinsonNet in Czechia
por: Gal, Ota, et al.
Publicado: (2017)

The Category of Conventional Physiotherapy: The Case of Parkinson’s Disease Guidelines
por: Hoskovcová, Martina, et al.
Publicado: (2022)

Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease
por: Kim, Ji Hee, et al.
Publicado: (2015)

Brain Damage With Heart Failure: Cardiac Biomarker Alterations and Gray Matter Decline
por: Mueller, Karsten, et al.
Publicado: (2020)

FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: A whole-brain multimodal imaging meta-analysis
por: Albrecht, Franziska, et al.
Publicado: (2018)

Disentangling brain functional network remodeling in corticobasal syndrome – A multimodal MRI study
por: Ballarini, Tommaso, et al.
Publicado: (2019)

Combined and Sequential Treatment with Deep Brain Stimulation and Continuous Intrajejunal Levodopa Infusion for Parkinson’s Disease
por: van Poppelen, Daniël, et al.
Publicado: (2021)

The acute brain response to levodopa heralds dyskinesias in Parkinson disease
por: Herz, Damian M., et al.
Publicado: (2014)

Normalization effect of levodopa on hierarchical brain function in Parkinson’s disease
por: Guo, Tao, et al.
Publicado: (2022)

Morphologic brain network predicts levodopa responsiveness in Parkinson disease
por: Xie, Yongsheng, et al.
Publicado: (2023)

Parkinson’s Kinetigraph in the Selection of Levodopa-Carbidopa Intestinal Gel for Motor Fluctuations Refractory to Deep Brain Stimulation
por: Noui, Yassine, et al.
Publicado: (2021)

Short-term effect of dopaminergic medication on speech in early-stage Parkinson’s disease
por: Tykalova, Tereza, et al.
Publicado: (2022)

Parkin (PARK 2) Mutations Are Rare in Czech Patients with Early-Onset Parkinson's Disease
por: Fiala, Ondrej, et al.
Publicado: (2014)

The Relationship Between Electrical Energy Delivered by Deep Brain Stimulation and Levodopa-Induced Dyskinesias in Parkinson's Disease: A Retrospective Preliminary Analysis
por: Prenassi, Marco, et al.
Publicado: (2021)

Distinct patterns of speech disorder in early-onset and late-onset de-novo Parkinson’s disease
por: Rusz, Jan, et al.
Publicado: (2021)

Evaluation of the Direct Effect of Bilateral Deep Brain Stimulation of the Subthalamic Nucleus on Levodopa-Induced On-Dyskinesia in Parkinson's Disease
por: Li, Jiping, et al.
Publicado: (2021)

Short- and Long-Term Effects of DBS on Gait in Parkinson's Disease
por: Brozova, Hana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_33gqvkfeea98f8vnlqrp5duflu